Medical News

RSS
Low doses of anticancer drug can prevent development of diabetes mellitus type 1

Low doses of anticancer drug can prevent development of diabetes mellitus type 1

Antipsychotic medication can actively combat cells of difficult-to-treat form of ALL

Antipsychotic medication can actively combat cells of difficult-to-treat form of ALL

Researchers develop personalized tool to predict likelihood of prostate cancer overdiagnosis

Researchers develop personalized tool to predict likelihood of prostate cancer overdiagnosis

Study provides details to help scientists design better vaccines for Plasmodium vivax

Study provides details to help scientists design better vaccines for Plasmodium vivax

TSRI researchers develop new fluid biopsy technique to identify patients at high risk of heart attack

TSRI researchers develop new fluid biopsy technique to identify patients at high risk of heart attack

More insurers extend premium payment deadlines

More insurers extend premium payment deadlines

Akorn acquires NDA and all rights to Betimol from Santen

Akorn acquires NDA and all rights to Betimol from Santen

Altheus Therapeutics completes enrollment for Phase 2 trial of Zoenasa Rectal Gel for distal ulcerative colitis

Altheus Therapeutics completes enrollment for Phase 2 trial of Zoenasa Rectal Gel for distal ulcerative colitis

Thirty-one students complete Maddie's Online Graduate Certificate in Shelter Medicine

Thirty-one students complete Maddie's Online Graduate Certificate in Shelter Medicine

Attenuated psychosis syndrome shows clinical significance

Attenuated psychosis syndrome shows clinical significance

Bipolar screening tools not tailored to young people

Bipolar screening tools not tailored to young people

New study compares blood pressure management in the US and England

New study compares blood pressure management in the US and England

Gastric bypass and cardiovascular disease risk: an interview with Dr. Brethauer, Cleveland Clinic

Gastric bypass and cardiovascular disease risk: an interview with Dr. Brethauer, Cleveland Clinic

Trevena doses first patient in TRV027 Phase 2b trial for acute heart failure

Trevena doses first patient in TRV027 Phase 2b trial for acute heart failure

Biogen Idec, Sangamo BioSciences partner to develop therapeutics for hemoglobinopathies

Biogen Idec, Sangamo BioSciences partner to develop therapeutics for hemoglobinopathies

Mylan announces launch of Mycophenolic Acid Delayed-release Tablets

Mylan announces launch of Mycophenolic Acid Delayed-release Tablets

Zyomyx's MyT4 point-of-care CD4 diagnostic test receives CE mark approval

Zyomyx's MyT4 point-of-care CD4 diagnostic test receives CE mark approval

First Edition: January 9, 2014

First Edition: January 9, 2014

Nottingham scientists exploit MRI technology to assist in the treatment of IBS

Nottingham scientists exploit MRI technology to assist in the treatment of IBS

Zymeworks, ImClone Systems partner to develop novel bi-specific antibody oncology therapeutics

Zymeworks, ImClone Systems partner to develop novel bi-specific antibody oncology therapeutics

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.